Coegin Pharma has a solid patent portfolio with 21 patent families including substance patents, user patents, combination patents and formulation patents. The patent families in the table below have been filed in the United States, Europe, Canada, Japan, Australia and also in other areas such as China, Hong Kong, Korea, India, Israel, New Zealand and Norway
|
Selected patent families |
|
|
Novel compositions and uses thereof |
PCT/GB2012/051955 |
|
Peptides for treatment of diabetes |
PCT/EP2018/061547 |
|
Peptides fragments for treatment of diabetes |
PCT/EP2019/080563 |
|
Topical formulation of FOL005 |
PCT/EP2020/061453 |
|
Peptides for use in skin and hair pigmentation |
PCT/EP2021/080032 |
|
AVX001/AVX002 type compounds – treatment of psoriasis
|
PCT/GB03/000364 |
|
AVX001 type ketones for the treatment of glomerulonephritis |
PCT/EP2010/003384 |
|
Oxothiazole compounds and their use for the treatment of certain chronic inflammatory conditions |
PCT/2010/064687 |
|
Oxothiazole compounds and their use in the treatment of chronic inflammatory disorders and proliferative disorders such as cancer |
PCT/EP2014/051655 |
|
Oxothiazole compounds and their use for the treatment of chronic inflammatory disorders and proliferative disorders such as cancer |
PCT/EP2015/067836 |
|
AVX001 type ketones for the treatment of skin cancer |
PCT/EP2015/061534 |
|
AVX001 and AVX002 in combination with BEZ235 |
PCT/EP2017/056022 |
|
AVX235 and AVX420 in combination with BEZ235 |
PCT/EP2017/056016 |
|
Formulation comprising AVX001 type ketones and silicone |
PCT/EP2017/073951 |
|
Oxothiazole compounds in combination with a secosteroid |
PCT/EP2017/078169 |
|
Oxothiazole compounds in combination with a corticosteroid |
PCT/EP2017/078162 |
|
AVX001 type ketones for the treatment of fibrotic diseases |
PCT/EP2018/066028 |
|
Oxothiazole compounds for the treatment of fibrotic diseases |
PCT/EP2019/060544 |
|
AVX001/AVX002 type compounds for use in the prevention of metastasis in cancer |
PCT/EP2020/071168 |
|
Novel compositions and uses thereof |
PCT/GB2012/051955 |
|
Peptides for treatment of diabetes |
PCT/EP2018/061547 |